Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Arbutus Biopharma Corp | Interim President & CEO, Director | Common Shares | 1.5M | $3.48M | $2.31 | Feb 2, 2024 | Direct |
Arbutus Biopharma Corp | Interim President & CEO, Director | Stock Option (Right to Buy) | 495K | Feb 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ABUS | Arbutus Biopharma Corp | Feb 1, 2024 | 3 | -$23.5K | 4 | Feb 5, 2024 | Interim President & CEO, Director |
ABUS | Arbutus Biopharma Corp | Feb 1, 2023 | 2 | $0 | 4 | Feb 3, 2023 | Chief Business Officer |
ABUS | Arbutus Biopharma Corp | Jan 20, 2022 | 1 | $916K | 4 | Jan 20, 2022 | Chief Business Officer |